Pune is becoming a testing ground for a different model of healthcare technology: diagnostic tools designed to work closer to patients and with less dependence on large laboratories. A Pune-based deep-tech venture is developing smartphone-linked and molecular diagnostic systems for sepsis, cancer and other conditions, highlighting how smaller clinical technologies could help address gaps in India’s uneven healthcare infrastructure.
The point of care diagnostics model is built around moving selected tests closer to where treatment begins. Instead of sending every sample through a central laboratory, portable systems can allow trained healthcare workers to collect and process information nearer to the patient. The approach could be particularly relevant to smaller hospitals and facilities where specialist laboratory capacity is limited. The Pune venture, established in 2018, has developed technologies combining biosensors, molecular testing and digital interfaces. Its current portfolio includes a sepsis screening system, while cancer-related work focuses on hepatocellular carcinoma and pancreatic cancer. The company also lists diagnostic applications for women’s health among its development areas. Its sepsis platform has attracted international recognition. The American Society of Mechanical Engineers selected the technology for its 2025 ISHOW India cohort, describing it as an AI-enabled system intended to support rapid sepsis detection and antimicrobial-resistance screening in resource-limited settings.
That focus matters because sepsis is a time-sensitive medical emergency. Delays in identifying the condition can complicate treatment, particularly in critical-care and neonatal settings. The technology is designed to bring several measurements into a portable workflow rather than relying entirely on conventional laboratory processes. However, clinical usefulness ultimately depends on diagnostic accuracy, regulatory clearance, affordability and how effectively hospitals incorporate the results into medical decisions. The wider significance is less about one device than about healthcare infrastructure. India’s expansion of hospitals and clinics does not automatically create equal access to specialist laboratories, trained technicians and advanced equipment. Point of care diagnostics can potentially reduce some of those geographic and infrastructure barriers, particularly when paired with reliable digital connectivity and appropriate clinical supervision.
Pune’s research ecosystem also provides a useful setting for such technologies to move from laboratory research towards commercial and clinical applications. The venture has received support through government-backed innovation programmes, while its development has been connected to the city’s research and incubation network. Yet decentralising diagnostics also creates new responsibilities. Devices used outside major laboratories require clear quality controls, secure handling of patient data, dependable power and connectivity, and trained personnel who understand when a result requires further clinical investigation. For cities seeking more resilient healthcare systems, the next step is therefore not simply to deploy more technology. It is to build a distributed network in which affordable diagnostics, skilled workers, digital infrastructure and referral hospitals work together. That is where Pune’s experiment could have its broader urban value.
